CI

At a glance

ClinicalIndex Comparison Record
N/ARecruiting· 1,000 target
Drug / intervention
ECIRSother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT05894668
NCT05894668N/ARecruitingHigh MomentumUpdated 22mo ago
CompareCT.gov

A Prospective Assessment of the Perioperative Parameter and Treatment Outcomes of Endoscopic Combined Intrarenal Surgery (ECIRS) in Asia

Chinese University of Hong Kong·observational·Posted Jun 8, 2023·Updated Aug 23, 2024

In Brief

An observational study evaluating ECIRS for Renal Stone. Currently recruiting, targeting 1,000 participants across 3 sites.

Signals

Enrolling ahead of pace

Detailed Summary

This is an observational, international, multicenter, cohort study, prospectively collecting clinical data registry on consecutive patients with urinary stone undergoing ECIRS.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsRenal Stone
CountriesHong Kong
Collaborators--

Timeline

N/ARecruiting
202420252026202720282029
First PostedJun 8, 2023
Enrollment StartAug 1, 2023
Primary CompletionDec 31, 2028
Study CompletionMar 31, 2029
TodayJul 1, 2026
Enrollment to primary: 5.4 yearsPosted 3.1 years agoPrimary completion in 2.5 years

Interventions

ECIRSother

Endoscopic Combined Intrarenal Surgery